Xponance’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,503
| Closed | -$213K | – | 1248 |
|
|
2021
Q2 | $213K | Sell |
1,503
-1,000
| -40% | -$142K | ﹤0.01% | 1168 |
|
|
2021
Q1 | $250K | Buy |
2,503
+272
| +12% | +$27.2K | 0.01% | 995 |
|
|
2020
Q4 | $276K | Sell |
2,231
-62
| -3% | -$7.67K | 0.01% | 969 |
|
|
2020
Q3 | $223K | Buy |
2,293
+65
| +3% | +$6.32K | 0.01% | 945 |
|
|
2020
Q2 | $348K | Buy |
+2,228
| New | +$348K | 0.01% | 769 |
|